Perioperative Chemoradiotherapy for Potentially Resectable Gastric Cancer
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00420394|
Recruitment Status : Unknown
Verified January 2007 by Soroka University Medical Center.
Recruitment status was: Recruiting
First Posted : January 11, 2007
Last Update Posted : June 20, 2007
Rationale: Adjuvant chemoradiation considered as standard of care after curative surgery for adenocarcinoma of stomach and gastroesophageal cancer. Preoperative chemotherapy in the in locally advanced gastric cancer results in significant tumoral downstaging with improved rate of curative resections.
Purpose: To evaluate feasibility and safety of combination of preoperative chemotherapy and postoperative chemoradiation for locally advanced adenocarcinoma of stomach and gastroesophageal cancer
|Condition or disease||Intervention/treatment||Phase|
|Stomach Neoplasms||Procedure: Chemotherapy Procedure: surgery Procedure: radiotherapy||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||30 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Phase II Study of Preoperative Chemotherapy and Postoperative Chemo-Radiation for Newly Diagnosed, Potentially Resectable Gastric Cancer|
|Study Start Date :||April 2007|
- Feasibility of the study regimen.
- Rate of R0 resection following chemotherapy.
- Morbidity and mortality of surgery following chemotherapy.
- Overall and progression free survival following the study treatment plan
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00420394
|Contact: Margarita Tokar, MD||+972-8-6400768||Ritato@clalit.org.il|
|Contact: Dmitri Bobilev, MDemail@example.com|
|Soroka University Medical Center,Oncology Center||Recruiting|
|Contact: margarita Tokar, MD +972-86400768 firstname.lastname@example.org|
|Sub-Investigator: Konstantin Lavrenkov, MD|
|Study Chair:||Margarita Tokar, MD||Soroka University Medical Center and Ben-Gurion University of the Negev|